Novavax (NASDAQ: NVAX), lub tuam txhab biotechnology, tsis ntev los no tau tshaj tawm hauv xov xwm tshaj tawm tias lawv tau ua tiav lawv qhov kev faib tawm ntawm Senior Convertible Notes sib npaug ntawm $ 175.25 lab dhau 2027 nrog rau $ 74.75 lab nyiaj pub dawb rau pej xeem. Lub tuam txhab tau hais tias cov nyiaj tau los tau xav tias yuav nyob ib puag ncig $ 166 lab. NVAX Tshuag tau nce ntau dua 2%, tam sim no ua lag luam ntawm $ 9.06 ntawm lub sijhawm tshaj tawm.
Novavax Muag Senior Convertible Notes to Trusted Partys
Raws li kev tso tawm, cov ntawv sau tau muab thiab muag rau cov neeg ntseeg siab xwb. Tsis tas li ntawd, lub tuam txhab tau muab kev rhuav tshem ntawm cov kev pabcuam no qhov twg 5% Cov Ntawv Tshaj Lij Tshaj Lij Tshaj Lij tau suav txog $ 150 lab thaum lub tuam txhab kaw thawj qhov kev xaiv yuav tau txais mus txog $ 25.25 lab ntxiv. Lawv kuj tau ua tiav cov ntawv sau nyiaj txiag pej xeem ntawm 7,475,000 feem ntau sib koom ua ke nrog rau cov neeg sau ntawv xaiv los yuav txog 975,000 cov khoom ntxiv.
NVAX Stock Price Analysis
Daim duab qhia tau hais tias cov tuam txhab shares tau poob yuav luag 90% tus nqi txij thaum Lub Xya Hli 2022. Kev hloov pauv tau qhia tias cov neeg muag khoom pheej yig hauv kev ua lag luam thaum cov neeg yuav khoom tseem nyiam cov khoom lag luam. Tus txheeb ze lub zog index taw tes rau kev nce siab, qhov qhia tau zoo rau tus nqi. Qhov xwm txheej tau txhawb nqa los ntawm qhov tseeb tias cov khoom lag luam twb tau nkag mus rau thaj tsam oversold.
Thaum Lub Xya Hli 2022, cov khoom lag luam tus nqi nce mus txog qhov siab ntawm $ 77 ua raws li qhov poob qis rau lub lim tiam tom ntej. Lub quarter 2 daim ntawv qhia nyiaj tau los muaj kev cuam tshuam loj heev vim tus nqi qhib ntawm $ 40 los ntawm hnub dhau los ze ntawm $ 57, yuav luag 30% poob hauv ib hnub. Shares tau txij li thaum tuav lub "nthwv dej" uas thaum kawg coj cov tuam txhab sib koom ua ke. Tam sim no, anched VWAP qhia tau hais tias nyuaj heev kom ncav cuag kev tiv thaiv ntawm $ 28.
Cov nyiaj khwv tau los hauv peb lub hlis twg qhia txog 25.3% surprise hauv cov nyiaj tau los, tsim tau $ 734.58 lab nyob rau hauv qhov sib piv rau qhov kwv yees ntawm $ 586.25 lab. Cov nyiaj tau los ntawm ib feem (EPS) qhia tias poob ntawm $ 2.15 tawm tsam qhov kwv yees ntawm $ 1.57 EPS zoo. Nyob rau sab ci ntsa iab, cov paj tau paj tau nce ntxiv thaum Q3 2022 rau (26.84%) los ntawm (274.57%) hauv lub quarter dhau los.
Nyuam qhuav pib lub hlis no, Lub Tebchaws Yelemes Pawg Neeg Saib Xyuas Kev Tiv Thaiv ntawm Robert Koch Institute (STIKO) tau pom zoo Nuvaxovid ua covid booster rau 18 xyoo thiab laus dua. Cov lus tshaj tawm tuaj tom qab kev sim tshuaj tiv thaiv hauv Asmeskas thiab Australia. Food and Drug Administration (FDA) thiab Vaccines and Related Biological Products Advisory Committee (VRBPAC) tau tshuaj xyuas NVX-CoV2373 tiv thaiv SARS-CoV-2 thaum lub Tsib Hlis 2022.
Tsis ntev los no covidid tshwm sim tau ua rau muaj kev ntshai thoob ntiaj teb, ua rau muaj kev xav txog kev kaw hauv tebchaws. Raws li CNBC, Asmeskas tau sau npe 100 lab tus neeg mob covid hauv ib lub lis piam. BBC tau tshaj tawm tias cov neeg nkag los ntawm Tuam Tshoj, Hong Kong thiab Macau xav tau kev sim thaum lawv nkag hauv lub tebchaws. Kev kis thoob qhov txhia chaw yuav yog xov xwm tsis zoo rau ntau lub tuam txhab tab sis kuj tseem muaj txoj hauv kev loj hlob rau cov koom haum hauv kev lag luam kev noj qab haus huv xav tias yuav muaj kev paub ntau ntxiv thaum lub sijhawm tawg.
Tau qhov twg los: https://www.thecoinrepublic.com/2022/12/29/nvax-stock-close-to-breakdown-amid-covid-breakout/